echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > The first domestic innovative preparation of ropivacaine multivesicular liposome is about to enter the clinic

    The first domestic innovative preparation of ropivacaine multivesicular liposome is about to enter the clinic

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Luye Pharmaceutical Group announced that the clinical trial application of its independently developed innovative preparation-Ropivacaine Hydrochloride Liposome Suspension Injection (LY09606) has been accepted by the Drug Evaluation Center of the National Medical Products Administration and will soon enter the clinical stage .


    Ropivacaine is the first pure L-body long-acting amide local anesthetic, with dual effects of anesthesia and analgesia; large doses can produce surgical anesthesia, while small doses can produce sensory block (analgesia) with only limitations Of non-progressive motor nerve block.


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.